Boston Scientific BSX posted an adjusted gross margin of 71% in the third quarter of 2025, representing a 60-basis-point (bps) improvement compared to the prior-year period. The increase was mainly ...

Boston Scientific today announced a collaboration with Epic, a leading electronic health record (EHR) software developer.

Boston Scientific is making it easier for doctor to get radioactive TheraSphere treatments to patients when and where they ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Boston Scientific today announced a catheter development and commercialization deal with Siemens Healthineers.

Boston Scientific (NYSE: BSX) has more than doubled in value since early January 2021 – jumping from levels of $36 then to around $82 now – vs. an increase of about 45% for the S&P 500 over this ...

Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston ...

Miriam O’Sullivan, senior vice president and chief human resources officer at Boston Scientific PHOTO I COURTESY OF BOSTON SCIENTIFIC Marlborough medical device manufacturer Boston Scientific has ...

Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance, the modest ...

Marlborough medical device manufacturing firm Boston Scientific looks to soon add stroke prevention treatment to its portfolio, as the manufacturer has entered into a $1.16 billion agreement to ...